BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712
225 results:

  • 1. Narrow interval dual phase 18F-FDG PET/CT: A practical approach for distinguishing tumor recurrence from radiation necrosis in brain metastasis.
    Aggarwal A; Aggarwal AK; Prakash S; Vile DJ; Aggarwal A
    Medicine (Baltimore); 2024 May; 103(18):e37789. PubMed ID: 38701250
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases.
    Mayo ZS; Billena C; Suh JH; Lo SS; Chao ST
    Neuro Oncol; 2024 Mar; 26(12 Suppl 2):S56-S65. PubMed ID: 38437665
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficacy of hypofractionated Gamma Knife radiosurgery in treating surgical beds of metastatic brain tumors.
    Samanci Y; Ali Tepebasili M; Deniz Ardor G; Haluk Duzkalir A; Orbay Askeroglu M; Peker S
    J Clin Neurosci; 2024 Mar; 121():105-113. PubMed ID: 38387112
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Simultaneous evaluation of brain metastasis and thoracic cancer using semiconductor
    Kaneko K; Nagao M; Ueda K; Yamamoto A; Sakai S
    Ann Nucl Med; 2024 Apr; 38(4):278-287. PubMed ID: 38386272
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Radiation necrosis after radiation therapy treatment of brain metastases: A computational approach.
    Ocaña-Tienda B; León-Triana O; Pérez-Beteta J; Jiménez-Sánchez J; Pérez-García VM
    PLoS Comput Biol; 2024 Jan; 20(1):e1011400. PubMed ID: 38289964
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review.
    Li C; Li K; Zhong S; Tang M; Shi X; Bao Y
    Crit Rev Oncol Hematol; 2024 Feb; 194():104227. PubMed ID: 38220124
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparison of Gamma Knife (GK) and Linear Accelerator (LINAC) radiosurgery of brain metastasis resection cavity: a systematic review and proportional meta-analysis.
    Dharnipragada R; Dusenbery K; Watanabe Y; Ferreira C; Chen CC
    Clin Exp Metastasis; 2024 Feb; 41(1):1-8. PubMed ID: 37943360
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Preoperative Versus Postoperative Radiosurgery of brain Metastases: A Meta-Analysis.
    Dharnipragada R; Dusenbery K; Ferreira C; Sharma M; Chen CC
    World Neurosurg; 2024 Feb; 182():35-41. PubMed ID: 37918565
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients.
    Lehrer EJ; Khosla AA; Ozair A; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Mathieu D; Trudel C; Deibert CP; Malouff TD; Ruiz-Garcia H; Peterson JL; Patel S; Bonney P; Hwang L; Yu C; Zada G; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Fakhoury KR; Rusthoven CG; Dickstein DR; Sheehan JP; Trifiletti DM; Ahluwalia MS
    J Neurooncol; 2023 Oct; 165(1):63-77. PubMed ID: 37889444
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The 5-factor modified frailty index as a prognostic factor of stereotactic radiosurgery for metastatic disease to the brain.
    Lucido T; Rajkumar S; Rogowski B; Meinert J; Elhamdani S; Liang Y; Karlovits S; Yu A; Wegner RE; Shepard MJ
    J Neurosurg; 2024 Apr; 140(4):929-937. PubMed ID: 37856413
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multimodal imaging-based material mass density estimation for proton therapy using supervised deep learning.
    Chang CW; Marants R; Gao Y; Goette M; Scholey JE; Bradley JD; Liu T; Zhou J; Sudhyadhom A; Yang X
    Br J Radiol; 2023 Dec; 96(1152):20220907. PubMed ID: 37660372
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Dose-Volume Tolerance of the brain and Predictors of Radiation Necrosis After 3-Fraction Radiosurgery for brain Metastases: A Large Single-Institutional Analysis.
    Upadhyay R; Ayan AS; Jain S; Klamer BG; Perlow HK; Zoller W; Blakaj DM; Beyer S; Grecula J; Arnett A; Thomas E; Chakravarti A; Raval RR; Palmer JD
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):275-284. PubMed ID: 37574170
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis.
    Jablonska PA; Muniz T; Ribeiro M; Liu ZA; Ye XY; Devaraja K; Laperriere N; Millar BA; Conrad T; Kongkham P; Butler M; Shultz DB
    J Neurooncol; 2023 Aug; 164(1):199-209. PubMed ID: 37552363
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Deuterium Magnetic Resonance Spectroscopy Quantifies Tumor Fraction in a Mouse Model of a Mixed Radiation Necrosis / GL261-Glioblastoma Lesion.
    Song KH; Ge X; Engelbach J; Rich KM; Ackerman JJH; Garbow JR
    Mol Imaging Biol; 2024 Feb; 26(1):173-178. PubMed ID: 37516675
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A Systematic Review Informing the Management of Symptomatic brain Radiation Necrosis After Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society Recommendations.
    Vellayappan B; Lim-Fat MJ; Kotecha R; De Salles A; Fariselli L; Levivier M; Ma L; Paddick I; Pollock BE; Regis J; Sheehan JP; Suh JH; Yomo S; Sahgal A
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):14-28. PubMed ID: 37482137
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis.
    Layer JP; Hamed M; Potthoff AL; Dejonckheere CS; Layer K; Sarria GR; Scafa D; Koch D; Köksal M; Kugel F; Grimmer M; Holz JA; Zeyen T; Friker LL; Borger V; Schmeel FC; Weller J; Hölzel M; Schäfer N; Garbe S; Forstbauer H; Giordano FA; Herrlinger U; Vatter H; Schneider M; Schmeel LC
    J Neurooncol; 2023 Aug; 164(1):107-116. PubMed ID: 37477822
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis.
    Calderon B; Vazquez L; Belkacemi M; Pourel N
    Eur J Med Res; 2023 Jul; 28(1):233. PubMed ID: 37443046
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Transcriptional expression of radiation-induced early cortical morphological alterations and its association with radiation necrosis in patients with nasopharyngeal carcinoma.
    Lin X; Guo Z; Lin S; Qiu Y
    Radiother Oncol; 2023 Sep; 186():109770. PubMed ID: 37385380
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
    Moore-Palhares D; Chen H; Keith J; Wang M; Myrehaug S; Tseng CL; Detsky J; Perry J; Lim-Fat MJ; Heyn C; Maralani P; Lipsman N; Das S; Sahgal A; Soliman H
    J Neurooncol; 2023 Jul; 163(3):541-551. PubMed ID: 37256526
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Safety and efficacy of Cesium-131 brachytherapy for brain tumors.
    Bander ED; Kelly A; Ma X; Christos PJ; Wernicke AG; Stieg PE; Trichter S; Knisely JPS; Ramakrishna R; Schwartz TH
    J Neurooncol; 2023 Jun; 163(2):355-365. PubMed ID: 37249824
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.